News & Updates

Dapagliflozin improves symptoms, physical limitations in HFpEF
Dapagliflozin improves symptoms, physical limitations in HFpEF
13 Oct 2021 byRoshini Claire Anthony

Patients with heart failure and preserved ejection fraction (HFpEF) treated with dapagliflozin experienced improvements in symptoms and physical limitations, according to results of the PRESERVED-HF study presented at HFSA 2021.

Dapagliflozin improves symptoms, physical limitations in HFpEF
13 Oct 2021
Wheat bran with RPS boosts serum SCFAs in obese people without improving health parameters
Wheat bran with RPS boosts serum SCFAs in obese people without improving health parameters
13 Oct 2021
Older age, CRP portend deaths in COVID-19 patients with diabetes
Older age, CRP portend deaths in COVID-19 patients with diabetes
13 Oct 2021
Sustained caloric restriction reduces more fat than muscle, organ tissue
Sustained caloric restriction reduces more fat than muscle, organ tissue
12 Oct 2021

Calorie restriction (CR) for 2 years in young individuals without obesity significantly impacts body composition, including a preferential loss of adipose tissue, such as visceral fat, over muscle and organ tissue, a recent study has shown.

Sustained caloric restriction reduces more fat than muscle, organ tissue
12 Oct 2021
Obesity may predispose individuals to early-onset colorectal adenocarcinoma
Obesity may predispose individuals to early-onset colorectal adenocarcinoma
12 Oct 2021

Individuals with obesity are at higher risk of developing early-onset colorectal adenocarcinoma compared with their normal-weight counterparts, as reported in a study.

Obesity may predispose individuals to early-onset colorectal adenocarcinoma
12 Oct 2021
CV risk remains elevated in metabolically healthy obese
CV risk remains elevated in metabolically healthy obese
08 Oct 2021 byRoshini Claire Anthony

Individuals who are obese but without metabolic abnormalities (metabolically healthy obese [MHO]) have an elevated risk of developing MACE-HF*, new-onset heart failure (HF), and new-onset atrial fibrillation (AF), according to a French study presented at EASD 2021.

CV risk remains elevated in metabolically healthy obese
08 Oct 2021